GBI Research

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research i
nclude:

  • Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research.
  • Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography.
  • Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered.
  • Market Profiles: overview-level reports based on market, company and demographic data.
  • Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.
GBI Research
 

List of reports from GBI Research

< prev 1    3  4  5  6  7  8  9  10  
Frontier Pharma: Asthma - Identifying and Commercializing First-in-Class Innovation
5/1/2015 | published by: GBI Research
... range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape. More pertinently, the degree and proportion of breakthrough innovations is significant. GBI Research analysis ...  |  read more...
USD 6,995
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs
5/1/2015 | published by: GBI Research
... its latest research, Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 - Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite Brand Erosion of Blockbuster Anti-TNFs, which provides in-depth analysis of Rheumatoid Arthritis (RA) ...  |  read more...
USD 4,995
Frontier Pharma: Duchenne Muscular Dystrophy and Becker Muscular Dystrophy - Identifying and Commercializing First-in-Class Innovation
5/1/2015 | published by: GBI Research
... 84 molecules across all stages of development. GBI Research’s analysis revealed a high degree of innovation and diversity in this indication, with 70% of the pipeline being first-in-class products, acting on 13 first-in-class targets. This ...  |  read more...
USD 6,995
Psoriasis Therapeutics in Asia-Pacific Markets to 2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth
5/1/2015 | published by: GBI Research
... Asia-Pacific Markets to 2021: Advent of Novel Biologics and Expanding Treatment Pool to Drive Growth, which provides insights into psoriasis therapeutics in the Asia-Pacific (APAC) market. For the purposes of this report, APAC refers to ...  |  read more...
USD 4,995
MRI Systems Market to 2020 - Focus on Patient Comfort and Operational Efficiency, with Growth Driven by Developing Economies
4/2/2015 | published by: GBI Research
... Operational Efficiency, with Growth Driven by Developing Economies discusses the market, competitive landscape, and trends for three MRI systems market segments: High-field, Mid-field, and Low-field MRI systems. It provides comprehensive information on the key trends ...  |  read more...
USD 3,500
Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 - Asia-Pacific
4/1/2015 | published by: GBI Research
... monitoring devices market segments: high acuity monitors, mid acuity monitors, low acuity monitors and multiparameter central stations. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: ...  |  read more...
USD 1,750
Market Digest: Ultrasound Systems Market 2006 to 2020 - Americas
3/9/2015 | published by: GBI Research
... stand-alone systems and portable systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: US, Brazil and Canada. It uses data and information sourced from proprietary ...  |  read more...
USD 1,750
Market Digest: Ultrasound Systems Market 2006 to 2020 - Europe
3/5/2015 | published by: GBI Research
... stand-alone systems and portable systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: Germany, France, UK, Italy and Spain. It uses data and information sourced ...  |  read more...
USD 1,750
Market Digest: Ultrasound Systems Market 2006 to 2020 - Asia-Pacific
3/5/2015 | published by: GBI Research
... stand-alone systems and portable systems. The analysis includes market size data by revenue and volume over the 2006–2020 period for the following countries: China, Japan, India and Australia. It uses data and information sourced from ...  |  read more...
USD 1,750
Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations
2/28/2015 | published by: GBI Research
... report,""Asthma Therapeutics in Major Developed Markets to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations"".The asthma therapeutics market is forecast to grow marginally over the forecast period across the ...  |  read more...
USD 4,995
Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Americas
2/1/2015 | published by: GBI Research
... the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes market size data by revenue and volume over the 2006–2020 ...  |  read more...
USD 1,750
Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches
1/31/2015 | published by: GBI Research
... in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches"". The report provides estimates of the market size for 2013, along with forecasts until 2020 for the Asia-Pacific markets of India, ...  |  read more...
USD 4,995
Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics
1/31/2015 | published by: GBI Research
... research, “Colorectal Cancer Therapeutics in Major Developed Markets to 2020 - Increased Uptake of High Priced Drugs to Offset the Impact of Generics”, which provides in-depth analysis of the Colorectal Cancer (CRC) therapeutics market in ...  |  read more...
USD 4,995
Frontier Pharma: Pain - Identifying and Commercializing First-in-Class Innovation
1/31/2015 | published by: GBI Research
... of molecular targets. GBI Research’s analyses identified 122 first-in-class programs in active development, constituting 13.6% of the pipeline and acting on 65 first-in-class molecular targets, indicating a high degree of innovation. This is in stark ...  |  read more...
USD 6,995
Frontier Pharma: Antibiotics - Identifying and Commercializing First-in-Class Innovation
12/31/2014 | published by: GBI Research
... majority (85%) are at the Discovery or Preclinical stages and have not yet entered human trials. Such a high proportion of drugs at the earliest stages of development would, in other indications, provide hope of ...  |  read more...
USD 6,995
Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth
12/31/2014 | published by: GBI Research
... progressive and currently incurable autoimmune disease that primarily affects joints. It is characterized by synovial inflammation and gradual bone erosion over many years, and disease progression results in stiffness and pain, especially in the hands ...  |  read more...
USD 4,995
Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation
12/31/2014 | published by: GBI Research
... the pipeline devoted to innovative products is considerably larger than both the industry and oncology average, which is a promising sign for novel therapeutics reaching the liver cancer market. The contrast between the market and ...  |  read more...
USD 6,995
Market Digest: Multiparameter Patient Monitoring Devices 2006 to 2020 - Europe (Germany, France, Italy, UK and Spain)
12/20/2014 | published by: GBI Research
... Italy, UK and Spain)” provides quantitative analysis of the four multiparameter patient monitoring devices market segments: high acuity monitors, mid acuity monitors, low acuity monitors and multiparameter central stations. The analysis includes market size data ...  |  read more...
USD 1,750
Frontier Pharma: Parkinson’s Disease - Identifying and Commercializing First-in-Class Innovation
11/30/2014 | published by: GBI Research
... but a stark contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market relies on symptomatic treatments that target neuromodulatory receptors, the pipeline shows a diverse ...  |  read more...
USD 6,995
Frontier Pharma: Alzheimer’s Disease - Identifying and Commercializing First-in-Class Innovation
11/30/2014 | published by: GBI Research
... GBI Research analysis revealed a high degree of innovation in this indication, with 46% of the pipeline being first-in-class products, acting on over 40 first-in-class molecular targets. In addition, the pipeline is characterized by the ...  |  read more...
USD 6,995
Frontier Pharma: Prostate Cancer - Identifying and Commercializing First-in-Class Innovation
11/30/2014 | published by: GBI Research
... across all stages. The range of mechanisms of action employed by these compounds is also highly diverse, especially in comparison to the existing market landscape. More pertinently, the degree and proportion of breakthrough innovations in ...  |  read more...
USD 6,995
Type 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth
11/30/2014 | published by: GBI Research
... 2 Diabetes Therapeutics in Asia-Pacific Markets to 2020 - Increasing Uptake of Novel Drug Classes to Drive Market Growth”, which provides insights into type 2 diabetes in the Asia-Pacific (APAC) markets of China, India, Japan ...  |  read more...
USD 4,995
Market Digest: Aesthetic Lasers and Energy Devices Market 2006 to 2020 - Asia-Pacific
11/18/2014 | published by: GBI Research
... the three aesthetic lasers and energy devices market segments: minimally invasive body contouring devices, non-invasive body contouring devices and laser resurfacing devices. The analysis includes market size data by revenue and volume over the 2006–2020 ...  |  read more...
USD 1,750
Picture Archiving and Communication Systems Market to 2020 - Digitization of Healthcare Systems and Evolution of PACS as a Decision Support Tool Drive Growth
10/31/2014 | published by: GBI Research
... to 2020 - Digitization of Healthcare Systems and Evolution of PACS as a Decision Support Tool Drive Growth” discusses the market, competitive landscape, and trends for two Picture Archiving and Communications Systems (PACS) market segments: ...  |  read more...
USD 3,500
Frontier Pharma: Non-Small Cell Lung Cancer - Identifying and Commercializing First-in-Class Innovation
10/31/2014 | published by: GBI Research
... contrast between the mechanisms of action employed in the current market and the pipeline is evident. Where the market comprises primarily ineffective chemotherapies that target tubulin or DNA replication, the pipeline shows an incredibly diverse ...  |  read more...
USD 6,995
< prev 1    3  4  5  6  7  8  9  10  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!